- On 28th January 2020
In 2019, we completed 23 clinical trials in the following therapeutic areas: IPF, Asthma, Atopic Dermatitis, COPD, Psoriasis, Alpha-1-Antitrypsin Deficiency, Hypertension, Graves’ Disease, Cystic Fibrosis and Healthy Volunteer studies.
Our average time from receiving final protocol to first subject was 1.6 months.
We began working with 5 new clients and 18 returning clients, ranging from global to mid-size pharma and biotechs.
We also underwent 10 sponsor audits with no critical or major findings.
We look forward to working with you this year!